A novel role of G protein-coupled receptor kinase 5 in urotensin II-stimulated cellular hypertrophy in H9c2UT cells

Mol Cell Biochem. 2016 Nov;422(1-2):151-160. doi: 10.1007/s11010-016-2814-y. Epub 2016 Sep 9.

Abstract

Urotensin II (UII) is a neural hormone that induces cardiac hypertrophy and may be involved in the pathogenesis of cardiac remodeling and heart failure. Hypertrophy has been linked to histone deacetylase 5 (HDAC5) phosphorylation and nuclear factor κB (NF-κB) translocation, both of which are predominantly mediated by G protein-coupled receptor kinase 5 (GRK5). In the present study, we found that UII rapidly and strongly stimulated nuclear export of HDAC5 and nuclear import of NF-κB in H9c2 cells overexpressing the urotensin II receptor (H9c2UT). Hence, we hypothesized that GRK5 and its signaling pathway may play a role in UII-mediated cellular hypertrophy. H9c2UT cells were transduced with a GRK5 small hairpin RNA interference recombinant lentivirus, resulting in the down-regulation of GRK5. Under UII stimulation, reduced levels of GRK5 in H9c2UT cells led to suppression of UII-mediated HDAC5 phosphorylation and activation of the NF-κB signaling pathway. In contrast, UII-mediated activations of ERK1/2 and GSK3α/β were not affected by down-regulation of GRK5. In a cellular hypertrophy assay, down-regulation of GRK5 significantly suppressed UII-mediated hypertrophy of H9c2UT cells. Furthermore, UII-mediated cellular hypertrophy was inhibited by amlexanox, a selective GRK5 inhibitor, in H9c2UT cells and neonatal cardiomyocytes. Our results suggest that GRK5 may be involved in a UII-mediated hypertrophic response via activation of NF-κB and HDAC5 at least in part by ERK1/2 and GSK3α/β-independent pathways.

Keywords: Cellular hypertrophy; G protein-coupled receptor kinase 5; Histone deacetylase 5; Nuclear factor κB; Small hairpin RNA; Urotensin II.

MeSH terms

  • Aminopyridines / pharmacology
  • Animals
  • Cell Line
  • G-Protein-Coupled Receptor Kinase 5 / genetics
  • G-Protein-Coupled Receptor Kinase 5 / metabolism*
  • Glycogen Synthase Kinase 3 beta / genetics
  • Glycogen Synthase Kinase 3 beta / metabolism
  • MAP Kinase Signaling System / drug effects*
  • MAP Kinase Signaling System / genetics
  • Mitogen-Activated Protein Kinase 3 / genetics
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Myocytes, Cardiac / enzymology*
  • Myocytes, Cardiac / pathology
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Rats
  • Urotensins / pharmacology*

Substances

  • Aminopyridines
  • NF-kappa B
  • Urotensins
  • urotensin II
  • amlexanox
  • Glycogen Synthase Kinase 3 beta
  • Gsk3b protein, rat
  • G-Protein-Coupled Receptor Kinase 5
  • Grk5 protein, rat
  • Mitogen-Activated Protein Kinase 3